Gerresheimer (ETR:GXI) Is Due To Pay A Dividend Of €1.25
May 29
Have your own idea? Try our Stock Screener
German (DAX) Life Sciences Industry Analysis
UpdatedMay 29, 2025
DataAggregated Company Financials
Companies4
- 7D-3.4%
- 3M-7.9%
- 1Y-12.5%
- YTD1.8%
Over the last 7 days, the Life Sciences industry has dropped 1.6%, driven by a pullback from Gerresheimer of 1.7%. In contrast, SCHOTT Pharma KGaA has gained 6.7%. Overall the industry is down 17% in 12 months. Looking forward, earnings are forecast to grow by 28% annually.
Industry Valuation and Performance
Has the German Life Sciences Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Thu, 29 May 2025 | €21.4b | €7.3b | €114.9m | 28.7x | 185.9x | 2.9x |
| Sat, 26 Apr 2025 | €21.1b | €7.3b | €112.4m | 26.6x | 187.5x | 2.9x |
| Mon, 24 Mar 2025 | €21.7b | €7.1b | €156.5m | 26.3x | 138.7x | 3x |
| Wed, 19 Feb 2025 | €22.8b | €7.1b | €161.1m | 26.7x | 141.8x | 3.2x |
| Fri, 17 Jan 2025 | €21.9b | €7.1b | €169.8m | 24.6x | 129.2x | 3.1x |
| Sun, 15 Dec 2024 | €21.9b | €7.1b | €169.8m | 24.1x | 128.8x | 3.1x |
| Tue, 12 Nov 2024 | €23.1b | €7.1b | €170.5m | 29.1x | 135.3x | 3.3x |
| Thu, 10 Oct 2024 | €22.9b | €7.1b | €177.5m | 29.6x | 129.2x | 3.2x |
| Sat, 07 Sep 2024 | €24.4b | €7.1b | €172.8m | 34x | 141.4x | 3.5x |
| Mon, 05 Aug 2024 | €25.0b | €7.0b | €237.1m | 35.7x | 105.3x | 3.5x |
| Wed, 03 Jul 2024 | €23.1b | €7.0b | €309.8m | 35.1x | 74.4x | 3.3x |
| Fri, 31 May 2024 | €24.3b | €7.0b | €333.3m | 30.3x | 73x | 3.5x |
| Sun, 28 Apr 2024 | €29.0b | €7.0b | €340.1m | 37.9x | 85.2x | 4.1x |
| Tue, 26 Mar 2024 | €34.2b | €7.1b | €384.5m | 37.7x | 88.9x | 4.8x |
| Thu, 22 Feb 2024 | €31.7b | €7.1b | €369.5m | 36.7x | 85.8x | 4.5x |
| Sat, 20 Jan 2024 | €28.7b | €7.3b | €507.1m | 33.6x | 56.6x | 3.9x |
| Mon, 18 Dec 2023 | €32.6b | €7.3b | €507.1m | 34.4x | 64.2x | 4.5x |
| Wed, 15 Nov 2023 | €27.2b | €7.3b | €507.1m | 29.5x | 53.6x | 3.7x |
| Fri, 13 Oct 2023 | €26.6b | €6.6b | €498.8m | 38.7x | 53.2x | 4x |
| Sun, 10 Sep 2023 | €29.1b | €6.6b | €498.1m | 42.2x | 58.5x | 4.4x |
| Tue, 08 Aug 2023 | €29.4b | €6.6b | €425.8m | 41.1x | 69.1x | 4.5x |
| Thu, 06 Jul 2023 | €27.5b | €6.7b | €487.3m | 38.2x | 56.3x | 4.1x |
| Sat, 03 Jun 2023 | €28.2b | €6.7b | €487.3m | 39.1x | 57.8x | 4.2x |
| Mon, 01 May 2023 | €28.0b | €6.7b | €483.0m | 38.8x | 58x | 4.2x |
| Wed, 29 Mar 2023 | €31.0b | €6.7b | €594.3m | 35.6x | 52.2x | 4.6x |
| Fri, 24 Feb 2023 | €31.9b | €6.6b | €588.7m | 35.2x | 54.2x | 4.8x |
| Sun, 22 Jan 2023 | €30.9b | €6.5b | €447.4m | 37.5x | 69x | 4.8x |
| Tue, 20 Dec 2022 | €26.9b | €6.5b | €447.4m | 32.6x | 60x | 4.2x |
| Thu, 17 Nov 2022 | €29.4b | €6.5b | €447.4m | 36.2x | 65.6x | 4.5x |
| Sat, 15 Oct 2022 | €28.1b | €6.2b | €573.0m | 52.2x | 49x | 4.5x |
| Mon, 12 Sep 2022 | €5.7b | €2.3b | €84.0m | 1257.2x | 67.9x | 2.5x |
| Wed, 10 Aug 2022 | €6.7b | €2.3b | €171.9m | 38.5x | 39.2x | 3x |
| Fri, 08 Jul 2022 | €6.3b | €2.2b | €174.9m | 35.7x | 36.1x | 2.8x |
| Sun, 05 Jun 2022 | €6.7b | €2.2b | €173.3m | 38.2x | 38.9x | 3x |
Price to Earnings Ratio
38.9x
Current Industry PE
- Investors are optimistic on the German Life Sciences industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 185x which is higher than its 3-year average PE of 83.9x.
- The 3-year average PS ratio of 3.8x is higher than the industry's current PS ratio of 2.9x.
Past Earnings Growth
- The earnings for companies in the Life Sciences industry have declined 13% per year over the last three years.
- Meanwhile revenues for these companies have grown 49% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.
Industry Trends
Which industries have driven the changes within the German Healthcare industry?
| DE Market | -0.80% | |
| Healthcare | -1.98% | |
| Life Sciences | -3.36% | |
| Clinical Research and Equipment | -3.36% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| GXI Gerresheimer | €64.05 | 5.0% +€105.3m | -37.4% | PE28.1x |
